An Update on Animal Models of Osteogenesis Imperfecta

被引:2
|
作者
Lv, Fang [1 ]
Cai, Xiaoling [1 ]
Ji, Linong [1 ]
机构
[1] Peking Univ Peoples Hosp, Dept Endocrinol & Metab, Xizhimen South St 11, Beijing 100044, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
Osteogenesis imperfecta; Mouse models; Zebrafish models; Mechanism; SCLEROSTIN ANTIBODY TREATMENT; TRANSGENIC MOUSE MODEL; MARROW STROMAL CELLS; OIM MICE EXHIBIT; BONE FRAGILITY; PROLYL; 3-HYDROXYLATION; RETROVIRUS INSERTION; MURINE MODEL; COLLAGEN; MUTATIONS;
D O I
10.1007/s00223-022-00998-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteogenesis imperfecta (OI) is a heterogeneous disorder characterized by bone fragility, multiple fractures, bone deformity, and short stature. In recent years, the application of next generation sequencing has triggered the discovery of many new genetic causes for OI. Until now, more than 25 genetic causes of OI and closely related disorders have been identified. However, the mechanisms of many genes on skeletal fragility in OI are not entirely clear. Animal models of OI could help to understand the cellular, signaling, and metabolic mechanisms contributing to the disease, and how targeting these pathways can provide therapeutic targets. To date, a lot of animal models, mainly mice and zebrafish, have been described with defects in 19 OI-associated genes. In this review, we summarize the known genetic causes and animal models that recapitulate OI with a main focus on engineered mouse and zebrafish models. Additionally, we briefly discuss domestic animals with naturally occurring OI phenotypes. Knowledge of the specific molecular basis of OI will advance clinical diagnosis and potentially stimulate targeted therapeutic approaches.
引用
收藏
页码:345 / 366
页数:22
相关论文
共 50 条
  • [21] Characterising and treating osteogenesis imperfecta
    Bishop, Nick
    EARLY HUMAN DEVELOPMENT, 2010, 86 (11) : 743 - 746
  • [22] Osteogenesis imperfecta: diagnosis and treatment
    Palomo, Telma
    Vilaca, Tatiane
    Lazaretti-Castro, Marise
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2017, 24 (06) : 381 - 388
  • [23] Osteogenesis imperfecta
    Herreros, M. B.
    Franco, R.
    Ascurra, M.
    PEDIATRIA-ASUNCION, 2008, 35 (01): : 33 - 37
  • [24] Recent Advances in Osteogenesis Imperfecta
    Cundy, Tim
    CALCIFIED TISSUE INTERNATIONAL, 2012, 90 (06) : 439 - 449
  • [25] OSTEOGENESIS IMPERFECTA
    BYERS, PH
    STEINER, RD
    ANNUAL REVIEW OF MEDICINE, 1992, 43 : 269 - 282
  • [26] Zebrafish Models for Skeletal and Extraskeletal Osteogenesis Imperfecta Features: Unveiling Pathophysiology and Paving the Way for Drug Discovery
    Masiero, Cecilia
    Aresi, Carla
    Forlino, Antonella
    Tonelli, Francesca
    CALCIFIED TISSUE INTERNATIONAL, 2024, 115 (06) : 931 - 959
  • [27] Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta
    Misof, Barbara M.
    Fratzl-Zelman, Nadja
    CALCIFIED TISSUE INTERNATIONAL, 2024, 115 (06) : 777 - 804
  • [28] Denosumab use in osteogenesis imperfecta: an update on therapeutic approaches
    Majdoub, Fatma
    Ferjani, Hanene Lassoued
    Ben Nessib, Dorra
    Kaffel, Dhia
    Maatallah, Kaouther
    Hamdi, Wafa
    ANNALS OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2023, 28 (02) : 98 - 106
  • [29] The Osteocyte Transcriptome Is Extensively Dysregulated in Mouse Models of Osteogenesis Imperfecta
    Zimmerman, Sarah M.
    Dimori, Milena
    Heard-Lipsmeyer, Melissa E.
    Morello, Roy
    JBMR PLUS, 2019, 3 (07)
  • [30] Recessively Inherited Forms of Osteogenesis Imperfecta
    Byers, Peter H.
    Pyott, Shawna M.
    ANNUAL REVIEW OF GENETICS, VOL 46, 2012, 46 : 475 - 497